GS-441524 30mg/ml 8ml Injection for Feline FIP Care

Product Overview

GS-441524 is an antiviral compound that has received significant attention in veterinary medicine, particularly in relation to feline infectious peritonitis (FIP). FIP is a serious disease caused by feline coronavirus and can develop in different clinical forms, making veterinary assessment an important part of treatment planning.

This GS-441524 injection is prepared at a concentration of 30mg/ml and supplied in an 8ml vial. The liquid dosage form provides a practical option for situations where an injectable preparation is selected as part of a veterinary treatment plan.

The product is intended for veterinary use and is supplied with clearly defined concentration and packaging information to help users distinguish it from other GS-441524 formulations.

Product Information

The 30mg/ml concentration means each milliliter contains 30mg of GS-441524. With 8ml in one vial, the total labeled amount is based on the stated concentration and fill volume.

Understanding Feline Infectious Peritonitis

FIP can affect cats of different ages and may present with a wide range of signs. Traditionally, veterinarians describe the disease according to its main clinical presentation, although individual cases can overlap.

Wet FIP

Wet FIP is associated with fluid accumulation within the abdominal or chest cavity. Affected cats may show abdominal enlargement, breathing difficulties, reduced appetite, weight loss, or general weakness.

Dry FIP

Dry FIP may involve inflammatory lesions in different organs. Clinical signs can therefore vary considerably from one cat to another and may include poor appetite, weight loss, persistent fever, or changes in general behavior.

Ocular or Neurological Involvement

Some cases involve the eyes or nervous system. These presentations require particular attention because clinical signs can be different from those seen in uncomplicated abdominal or systemic disease.

Recurrent Cases

Cats with a previous treatment history may require additional veterinary evaluation when clinical signs return. Recurrence should not automatically be assumed from a single symptom, so examination and appropriate diagnostic assessment remain important.

Why Concentration Matters

When working with an injectable product, concentration is an important part of calculating the required volume.

For this formulation:

30mg/ml = 30mg of GS-441524 in each 1ml of solution.

The 8ml vial therefore offers a larger fill volume than a 6ml presentation while keeping the same 30mg/ml concentration. This allows the product information to remain straightforward when calculating the amount contained in a measured volume.

The appropriate amount and frequency depend on factors such as the cat's body weight, clinical presentation, response to treatment, and veterinary assessment. For this reason, the concentration shown on the product label should always be considered together with the treatment plan rather than used independently.

Reference Administration Information

The following volume information is provided as reference material based on the supplied product information:

• Wet FIP: 0.3ml/kg body weight + 0.1ml residue
• Dry FIP: 0.4ml/kg body weight + 0.1ml residue
• Ocular / neurological involvement: 0.5ml/kg body weight + 0.1ml residue
• Recurrence: 0.6ml/kg body weight + 0.1ml residue

These figures are reference information rather than an individualized veterinary prescription. A qualified veterinarian should determine the appropriate treatment schedule for each cat.

A Practical Injectable Format

The 30mg/ml 8ml format is designed around a clearly identified concentration and vial volume. For veterinary professionals or buyers comparing different GS-441524 presentations, these two details make it easier to distinguish one formulation from another.

The 8ml vial format may also be considered when planning product quantities for an established veterinary treatment protocol. The actual amount required will vary according to the cat's body weight and the treatment approach selected by the veterinarian.

Because injectable products require appropriate handling, users should also pay attention to storage conditions, packaging integrity, labeling, and product information before use.

Product Handling and Storage

Keep the product at room temperature and store it in a suitable dry location away from excessive heat and direct environmental exposure.

Before use, the vial should be checked for visible changes, damage, leakage, or other unusual conditions. If the packaging appears compromised, professional advice should be obtained before the product is used.

Proper storage helps maintain the condition of the product throughout its stated shelf life. The expiry period for this product is one year from the manufacturing date.

Choosing the Right GS-441524 Presentation

GS-441524 may be supplied in different concentrations, vial sizes, and dosage forms. When comparing products, it is useful to look beyond the product name and confirm the actual concentration and fill volume.

For example, this product is identified as:

GS-441524 — 30mg/ml — 8ml/vial

This information distinguishes it from formulations using the same active ingredient but different concentrations or vial capacities.

For veterinary treatment planning, the concentration should always be considered alongside the prescribed volume. Using the wrong concentration can change the amount of active ingredient delivered, which is why checking the product label carefully is important.

Product Application

This GS-441524 injection is positioned for veterinary applications related to feline infectious peritonitis (FIP).

It may be considered within a veterinary treatment program for cats diagnosed with or being evaluated for FIP, including cases presenting with different clinical patterns. The specific treatment approach should be based on veterinary examination and the individual condition of the animal.

The product is not intended to replace veterinary diagnosis. FIP can resemble other feline diseases, and laboratory testing, clinical signs, imaging, and the cat's treatment history may all contribute to the diagnostic process.

Product Summary

For buyers looking for a clearly specified GS-441524 injectable formulation, the main product details are:

30mg/ml concentration, 8ml fill volume, injectable dosage form, CAS 1191237-69-0, and a stated application related to feline FIP treatment.

The formulation provides a defined concentration for veterinary treatment planning, while the 8ml vial offers a practical package size for users who need a larger fill volume than smaller vial presentations.

As with any veterinary treatment product, the concentration, volume, storage conditions, and treatment instructions should be checked carefully before use. Veterinary professionals should make the final decision regarding administration based on the individual cat and its clinical condition.